The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from a phase I/II study of CBP-1018, a bi-ligand–drug conjugate (Bi-XDC) as late line therapy for patients with metastatic castration resistant prostate cancer (mCRPC).
 
Kaiwen Li
No Relationships to Disclose
 
Jianming Guo
No Relationships to Disclose
 
Hongqian Guo
No Relationships to Disclose
 
Qi Zhang
No Relationships to Disclose
 
Hang Huang
No Relationships to Disclose
 
Liyan Zhou
No Relationships to Disclose
 
Junyong Dai
No Relationships to Disclose
 
Jimin Chen
No Relationships to Disclose
 
Lu Yang
No Relationships to Disclose
 
Xudong Yao
No Relationships to Disclose
 
Robert Huang
Employment - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
Leadership - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
Stock and Other Ownership Interests - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
 
Mo Xu
Employment - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
Leadership - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
 
Jing Zhang
Employment - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
 
en-Tzu Tang
Employment - Coherent Biopharma (Suzhou) Co., Ltd. Suzhou, Jiangsu, China
 
Yehui Shi
No Relationships to Disclose
 
Hai Huang
No Relationships to Disclose